SkinInjections

Juvelook injections

쥬베룩주사 · Korean term

Juvelook is a family of injectable products from the Korean company VAIM that combine poly-D,L-lactic acid (PDLLA) particles with hyaluronic acid. They are intended to stimulate the skin's own collagen gradually. Published evidence on PDLLA is mostly small and uncontrolled, and nodules and rare but serious injection complications have been reported.

On this page

Overview

AI-generated portrait of an adult East Asian woman in a consultation room.
AI-generated editorial illustration; not a patient result

Juvelook is a brand of injectable products made by VAIM Co., Ltd., which lists offices in Seoul and production in Daejeon, Korea [3]. The manufacturer describes it as a PDLLA-HA stimulator, combining poly-D,L-lactic acid (PDLLA) with hyaluronic acid (HA) [3]. An independent 2024 literature review on PDLLA also names Juvelook and VAIM [4].

What it is

PDLLA is a biodegradable polymer used as a "biostimulator": rather than simply filling a space, it is meant to trigger a mild, controlled inflammatory response that prompts the skin to make more collagen over time [4]. The manufacturer lists four versions with different amounts of PDLLA and HA: Juvelook, Juvelook Volume (also called Lenisna), Juvelook i and Juvelook Glam, each marketed for different areas [3]. These versions are not interchangeable, and Juvelook should not be assumed to behave like other PDLLA, PLLA or HA products.

What it involves

Juvelook is injected by a clinician. The manufacturer lists uses including overall skin rejuvenation, acne scars, the under-eye area and other concerns; these are the company's own claims [3]. Protocols varied across studies summarized by the review; it does not establish a patient schedule or an onset rule [4]. The version, treatment area, number of sessions and spacing should be decided by the treating clinician. This guide does not give doses or schedules.

Reasons to discuss it with a clinician and limits

Skin-rejuvenation treatment is optional. A consultation is a chance to talk about your goals, the alternatives (including no treatment) and which version, if any, suits your concern.

The evidence is limited. The 2024 review found that PDLLA studies were mostly small pilot studies, uncontrolled studies and case reports. Its authors note that the best way to prepare and inject the product, the right amount and the duration of effect are not yet established [4]. Much of the explanation of how PDLLA works comes from animal research rather than human trials [4]. Gradual collagen-related change is the aim, but it is not a guaranteed outcome.

Risks and considerations

Reported problems with PDLLA include lumps (nodules), which the review links to uneven spreading of the product, and inflammatory lumps (granulomas) [4]. Case reports also describe product moving from where it was placed and, rarely, serious blood-vessel complications, including vision loss and stroke [4]. For injectable fillers in general, the FDA lists bruising, redness, swelling and pain as common effects, and accidental injection into a blood vessel as the most serious risk, which can cause tissue death, blindness or stroke [2]. The FDA page does not discuss Juvelook or PDLLA, so it is general context only.

Recovery and follow-up

No product-specific recovery timeline was verified, so none is given. Common short-term effects of injectables, such as bruising, redness and swelling, are listed above [2]. The FDA advises urgent care for unusual pain, vision changes, white or blue-grey skin near the injection site, or signs of stroke after a filler injection [2]. Ask your clinician what aftercare they recommend and how to reach them if a lump or other problem appears.

Questions to ask

  • Which Juvelook version will be used, and why that one for my concern?
  • Is that version approved by Korea's Ministry of Food and Drug Safety for this use?
  • What published evidence supports it for my concern, and what is still uncertain?
  • How do you reduce the risk of lumps and blood-vessel injury, and what happens if a problem occurs?
  • What alternatives would you suggest, including no treatment?

Educational information. AI editorial and source checking are not clinical review. Checked 16 Nov 2026.

Category
Skin
General estimate
Not availableNo reviewed estimate exists. Clinic prices, when published, appear on each clinic profile.

Doctors who list juvelook injections

No doctors documented for this procedure yet.

A doctor appears here only when their scope is documented for this procedure at an exact clinic location.

Clinics that list juvelook injections

Offering evidence from each clinic’s own website. Availability and suitability need confirmation with the clinic.

No clinics list it yet.

Sources

Clinical references

  1. Dermal Fillers (Soft Tissue Fillers) · U.S. Food and Drug Administration (content current as of 6 July 2023) · Checked 16 Nov 2026
  2. JUVELOOK: A Bio-interactive PDLLA-HA Stimulator (manufacturer website, English) · VAIM Co., Ltd. (manufacturer) · Checked 16 Nov 2026
  3. Poly-d,l-lactic Acid (PDLLA) Application in Dermatology: A Literature Review · Polymers (MDPI), 2024; 16(18):2583; DOI 10.3390/polym16182583; full text via Europe PMC · Checked 16 Nov 2026
  4. 같은 주사인데 다른 규제…스킨부스터 시장 이중 트랙 이유는? (Same injection, different regulation: why the skin-booster market has a dual track) · Medical Times (Korea), 6 May 2026 · Checked 16 Nov 2026
Catalogue source
Source

This page is for research. It is not medical advice and is not a recommendation. Whether a treatment suits you, its risks and its cost need an individual consultation with a licensed doctor.

Online correction reports are not open yet.